Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer. [electronic resource]
Producer: 20080116Description: 1810-6 p. digitalISSN:- 1569-8041
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biopsy, Needle
- Camptothecin -- administration & dosage
- Capecitabine
- Colorectal Neoplasms -- drug therapy
- Confidence Intervals
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Humans
- Immunohistochemistry
- Irinotecan
- Liver Neoplasms -- drug therapy
- Male
- Maximum Tolerated Dose
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Risk Assessment
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.